Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.
Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).
Innovus is a specialty pharmaceutical company focused on OTC non –prescription drugs to improve men’s and women’s health. Innovus received approximately $3.85 million in gross proceeds from the sale of 25,666,669 shares common stock and an equal number of 1 and 5 year warrants sold at a price to the public of $.15 per share and $.15 exercise price of the warrants
The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia, Tom Rose and Associate Jay Yamamoto.
- Two Bright Sides of Estate Planning During COVID-19 - July 1, 2020
- Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock - June 26, 2020
- Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering - June 24, 2020